Volixibat (SHP626) is a highly selective, minimally absorbed, and competitive apical sodium-dependent bile acid transporter (ASBT) inhibitor. Volixibat has potential for treatment for non-alcoholic steatohepatitis (NASH)[1][2].
Molecular Weight:
805.95
CAS Number:
[1025216-57-2]
Formula:
C38H51N3O12S2
Target:
Apical Sodium-Dependent Bile Acid Transporter
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted